Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Matrix Scientific and Cord Blood America Sign Strategic Alliance Agreement for Stem Cell Banking.


SAN DIEGO -- Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP BMXP Boston Metropolitan Exchange Point ) announced today that it has signed a Strategic Alliance with Cord Blood America. Through this alliance, Cord Blood America will be marketing Bio-Matrix Scientific Group's adult adipose adipose /ad·i·pose/ (ad´i-pos)
1. fatty.

2. the fat present in the cells of adipose tissue.


ad·i·pose
adj.
Of, relating to, or composed of animal fat; fatty.
 stem cell banking and cryogenics services in addition to Bio-Matrix's cord blood stem cell banking.

Bio-Matrix Scientific Group and Cord Blood America plan to market Stem Cell cryo-storage utilizing Bio-Matrix's new San Diego-based 15,000-square-foot facility.

Bio-Matrix's Chairman & CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  David Koos stated: "The relationship we are evolving with Cord Blood America is the beginning of a new direction for stem cell banking. Together, Cord Blood and Bio-Matrix are taking stem cell banking from just cord blood into a new direction, the banking of adipose stem cells. In our opinion, these stem cells show great promise for the future in regenerative medicine. We believe Bio-Matrix's facility will be the first U.S. commercial stem cell bank housing adipose stem cells."

A Bio-Matrix spokesperson noted that the Cord Blood/Bio-Matrix alliance will:

--Have what both companies see as the highest level stem cell banking facility in the country

--Offer an opportunity to bank adult adipose stem cells, which show great promise for future therapies

--Leverage on each of the companies strengths within the stem cell banking industry

"We are very excited about the alliance with Cord Blood America and believe that this Business Alliance is an excellent fit for us. This Business Alliance will add significant value and benefits to our marketplace," stated Brian Pockett, Managing Director & COO of Bio-Matrix Scientific Group Inc.

About Cord Blood America

Cord Blood America, Inc. is a publicly traded company publicly traded company

A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market.
, governed by the United States Securities & Exchange Commission. Cord Blood America's stock trades on the NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
 OTC Bulletin Board OTC Bulletin Board

An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system.
 under the symbol: CBAI CBAI The Community Bankers Association of Illinois
CBAI Contract Bridge Association of Ireland (UK) 
. Cord Blood America has established itself as the platinum standard national competitor in the umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy.  storage industry.

About Bio-Matrix Scientific Group Inc.

Bio-Matrix Scientific Group Inc. is a development stage company in the business of medical devices and monitoring systems research, development and commercialization. Bio-Matrix Scientific Group Inc. is aligning itself with partners that offer key technologies in biomedical device development, tissue engineering, cell culturing, genome therapy and drug delivery systems. Other companies in the same industry as Bio-Matrix Scientific Group Inc. (Pink Sheets:BMXP) are Cord Blood America (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:CBAI), StemCells Inc. (NASDAQ:STEM) and Cryo-Cell International Inc. (OTCBB:CCEL).

More information will be available shortly on the Company's website: www.BMXGonline.com

DISCLAIMER: This news release contains forward-looking statements. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 25, 2005
Words:479
Previous Article:Legendary Musician Eric Clapton Gives Listeners a ``Sneak Peek''.
Next Article:Canadian Province Holds Hearings on Reduction of Drug Costs: VisualMED Invited to Present its Solutions to Minister and Parliamentary Commission.



Related Articles
Gift of Life.
LIFEBLOOD BANKING UMBILICAL CORD STEM CELLS FOR TREATMENT OF DISEASES SEEMS LIKE GOOD INSURANCE - BUT DOES THE POLICY REALLY PAY OFF?
Bio-Matrix Scientific Group Appoints Dr. Geoffrey O'Neill -- Formerly of Cryo-Cell International as New Bio-Matrix President.
Stem-cell ethics.
Bio-Matrix Announces Contract with Emergo Group Inc. for FDA cGMP/cGTP Compliance and ISO 13485:2003 Certification.
Bio-Matrix Scientific Group to Attend the 4th Annual International Umbilical Cord Blood Transplantation Symposium in Los Angeles.
Bio-Matrix Scientific Group Inc. Issues Update on Stem Cell Cryogenic Banking Facility.
CyGenics Selected In Top 3 Asian Technology Pioneers by World Economic Forum.
Bio-Matrix Scientific CEO Highlights Plans for First Commercial Adult Stem Cell Bank Derived from Fat and Medical Devices Aimed at Plastic Surgeons...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles